Ferring Pharmaceuticals appoints Alex Chang Senior Vice President, Asia Pacific
-Ferring Pharmaceuticals announced today that it has appointed Alex Chang to head the company’s Asia Pacific region effective 1 November 2013…
MISODEL™, Ferring’s removable misoprostol vaginal delivery system, approved for labour induction in European Decentralised Procedure
-Ferring Pharmaceuticals announced today that its MISODELTM (misoprostol) removable, controlled-release vaginal delivery system for labour induction…
Ferring announces second $3 million donation to the Royal Textile Academy of Bhutan
-Ferring Pharmaceuticals has announced a second $3 million donation to the Royal Textile Academy of Bhutan to support its mission to preserve and…
Ferring presents phase III data for a controlled release misoprostol vaginal delivery system for labour induction at the First European Congress on Intrapartum Care
-Data from the EXPEDITE study presented today at the First European Congress on Intrapartum Care (ECIC) demonstrated…
Ferring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action for chronic idiopathic constipation
-Ferring Pharmaceuticals today announced it has initiated enrolment of patients in two phase III clinical trials…
Archives Press release 2013
Archives Press release 2013